Literature DB >> 8972311

Monitoring tumour response.

J E Husband1.   

Abstract

Monitoring response to treatment of tumours is an increasingly important aspect of cancer radiology for several reasons. Firstly, the incidence of cancer is increasing and, furthermore, there have been major advances in treatment which have resulted in a larger number of patients surviving with treated tumours. Equally important is that there have been enormous advances in imaging over the past two decades which now permit us to obtain highly sophisticated information on tumour morphology and function using a variety of different techniques. In this review emphasis is placed on strategies for imaging in the follow-up of cancer patients and the information derived from current imaging techniques is described with particular reference to CT and MRI.

Entities:  

Mesh:

Year:  1996        PMID: 8972311     DOI: 10.1007/bf00240671

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  50 in total

1.  Human tumor fluorouracil trapping: clinical correlations of in vivo 19F nuclear magnetic resonance spectroscopy pharmacokinetics.

Authors:  C A Presant; W Wolf; M J Albright; K L Servis; R Ring; D Atkinson; R L Ong; C Wiseman; M King; D Blayney
Journal:  J Clin Oncol       Date:  1990-11       Impact factor: 44.544

2.  Use of MR imaging to assess results of chemotherapy for Ewing sarcoma.

Authors:  M A Lemmi; B D Fletcher; N M Marina; W Slade; D M Parham; J J Jenkins; W H Meyer
Journal:  AJR Am J Roentgenol       Date:  1990-08       Impact factor: 3.959

3.  Cancer statistics: a measure of progress.

Authors:  R E Lenhard
Journal:  CA Cancer J Clin       Date:  1996 Jan-Feb       Impact factor: 508.702

4.  Echo-planar imaging.

Authors:  R L DeLaPaz
Journal:  Radiographics       Date:  1994-09       Impact factor: 5.333

5.  Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma.

Authors:  M Hill; D Cunningham; D MacVicar; A Roldan; J Husband; R McCready; J Mansi; S Milan; T Hickish
Journal:  J Clin Oncol       Date:  1993-11       Impact factor: 44.544

6.  Residual abdominal masses after chemotherapy for nonseminomatous testicular cancer: correlation of CT and histology.

Authors:  P C Stomper; M S Jochelson; M B Garnick; J P Richie
Journal:  AJR Am J Roentgenol       Date:  1985-10       Impact factor: 3.959

Review 7.  Diagnostic techniques: their strengths and weaknesses.

Authors:  J Husband
Journal:  Br J Cancer Suppl       Date:  1980-04

8.  CT estimations of mean attenuation values and volume in testicular tumors: a comparison with surgical and histologic findings.

Authors:  J E Husband; D J Hawkes; M J Peckham
Journal:  Radiology       Date:  1982-08       Impact factor: 11.105

9.  Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy.

Authors:  U Haberkorn; L G Strauss; A Dimitrakopoulou; E Seiffert; F Oberdorfer; S Ziegler; C Reisser; J Doll; F Helus; G van Kaick
Journal:  J Nucl Med       Date:  1993-01       Impact factor: 10.057

10.  CT evaluation of treatment response in advanced gastric cancer.

Authors:  V W Ng; J E Husband; V M Nicolson; I Minty; A Bamias
Journal:  Clin Radiol       Date:  1996-03       Impact factor: 2.350

View more
  3 in total

Review 1.  Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors.

Authors:  D A Mankoff; F Dehdashti; A F Shields
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  Treatment response classification of liver metastatic disease evaluated on imaging. Are RECIST unidimensional measurements accurate?

Authors:  Michael Mantatzis; Stylianos Kakolyris; Kyriakos Amarantidis; Anastasios Karayiannakis; Panos Prassopoulos
Journal:  Eur Radiol       Date:  2009-02-24       Impact factor: 5.315

3.  Cancer imaging - the significance of the findings.

Authors:  R H Reznek
Journal:  Cancer Imaging       Date:  2000-10-09       Impact factor: 3.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.